Webinar: PARP Inhibitors: What you need to know

There is a great amount of excitement in the ovarian cancer community about the approval of three PARP Inhibitors for ovarian cancer treatment and maintenance therapy. Join ovarian cancer expert Dr. Ursula Matulonis to learn more about these new treatments: how they’re used now, how they differ from each other, and how they may be used in the future. This is a free webinar. A recording will be available following the presentation.

Support for OCRFA’s webinar series has been provided by Genentech.

Register for Webinar